We demonstrated that NAFLD and NASH provoke different grades of brain dysfunction, which are characterized by the altered expression of BA receptors, FXR and TGR5, and activation of microglia. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.